BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Inchingolo R, Posa A, Mariappan M, Spiliopoulos S. Locoregional treatments for hepatocellular carcinoma: Current evidence and future directions. World J Gastroenterol 2019; 25(32): 4614-4628 [PMID: 31528090 DOI: 10.3748/wjg.v25.i32.4614]
URL: https://www.wjgnet.com/2307-8960/full/v25/i32/4614.htm
Number Citing Articles
1
Anum Aslam, Amita Kamath, Bradley Spieler, Mark Maschiocchi, Carl F. Sabottke, Victoria Chernyak, Sara C. Lewis. Assessing locoregional treatment response to Hepatocellular Carcinoma: comparison of hepatobiliary contrast agents to extracellular contrast agentsAbdominal Radiology 2021; 46(8): 3565 doi: 10.1007/s00261-021-03076-x
2
Peter Konyn, Aijaz Ahmed, Donghee Kim. Current epidemiology in hepatocellular carcinomaExpert Review of Gastroenterology & Hepatology 2021; 15(11): 1295 doi: 10.1080/17474124.2021.1991792
3
Paolo Magistri, Stefano Di Sandro, Fabrizio Di Benedetto. Hepatocellular CarcinomaUpdates in Surgery 2023; : 97 doi: 10.1007/978-3-031-09371-5_12
4
Gitanjali Bajaj, Karthik Sundaram, Kedar Jambhekar, Roopa Ram. Imaging After Locoregional Therapy for Hepatocellular Carcinoma with Emphasis on LIRADS Treatment Response Assessment CriteriaSeminars in Ultrasound, CT and MRI 2021; 42(4): 318 doi: 10.1053/j.sult.2021.04.004
5
Lauren J. Delaney, Mohamed Tantawi, Corinne E. Wessner, Priscilla Machado, Flemming Forsberg, Andrej Lyshchik, Patrick O'Kane, Ji-Bin Liu, Jesse Civan, Allison Tan, Kevin Anton, Colette M. Shaw, John R. Eisenbrey. Predicting Long-Term Hepatocellular Carcinoma Response to Transarterial Radioembolization Using Contrast-Enhanced Ultrasound: Initial ExperiencesUltrasound in Medicine & Biology 2021; 47(9): 2523 doi: 10.1016/j.ultrasmedbio.2021.05.006
6
S. Lewis, A. Barry, M.A. Hawkins. Hypofractionation in Hepatocellular Carcinoma – The Effect of Fractionation SizeClinical Oncology 2022; 34(5): e195 doi: 10.1016/j.clon.2022.02.021
7
Neil Mehta. Hepatocellular Carcinoma—How to Determine Therapeutic OptionsHepatology Communications 2020; 4(3): 342 doi: 10.1002/hep4.1481
8
Yipeng Ma, Jiayu Ou, Tong Lin, Lei Chen, Junhui Chen, Mingjun Wang. Next Generation Sequencing‐Based Identification of T‐Cell Receptors for Immunotherapy Against Hepatocellular CarcinomaHepatology Communications 2021; 5(6): 1106 doi: 10.1002/hep4.1697
9
Kali Zhou, Neil Mehta. Downstaging to Liver TransplantClinics in Liver Disease 2020; 24(4): 665 doi: 10.1016/j.cld.2020.07.005
10
Zhitao Chen, Tielong Wang, Chuanbao Chen, Xitao Hong, Jia Yu, Yihao Ma, Yiwen Guo, Changjun Huang, Xiaoshun He, Weiqiang Ju, Maogen Chen, Irena Ilic. Circulating Tumor Cell Is a Clinical Indicator of Pretransplant Radiofrequency Ablation for Patients with Hepatocellular CarcinomaJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/7776389
11
Marija Radmilović-Radjenović, Nikola Bošković, Martin Sabo, Branislav Radjenović. An Analysis of Microwave Ablation Parameters for Treatment of Liver Tumors from the 3D-IRCADb-01 DatabaseBiomedicines 2022; 10(7): 1569 doi: 10.3390/biomedicines10071569
12
Charlotte Ebeling Barbier, Femke Heindryckx, Hans Lennernäs. Limitations and Possibilities of Transarterial Chemotherapeutic Treatment of Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2021; 22(23): 13051 doi: 10.3390/ijms222313051
13
Ozgul Ekmekcioglu, Omer Naci Tabakci, Nihal Bozdag Kaplan, Aylin Hasanefendioglu Bayrak, Muharrem Battal. Factors affecting the response to treatment and survival in hepatocellular carcinoma patients treated with transarterial radioembolisation: a single-centre experienceEuropean Journal of Gastroenterology & Hepatology 2021; 33(6): 926 doi: 10.1097/MEG.0000000000002117
14
Alexander E. Hare, Mina S. Makary. Interdisciplinary Cancer Research 2022;  doi: 10.1007/16833_2022_42
15
Bart Vanderborght, Sander Lefere, Hans Van Vlierberghe, Lindsey Devisscher. The Angiopoietin/Tie2 Pathway in Hepatocellular CarcinomaCells 2020; 9(11): 2382 doi: 10.3390/cells9112382
16
Cristina Micali, Ylenia Russotto, Grazia Caci, Manuela Ceccarelli, Andrea Marino, Benedetto Maurizio Celesia, Giovanni Francesco Pellicanò, Giuseppe Nunnari, Emmanuele Venanzi Rullo. Loco-Regional Treatments for Hepatocellular Carcinoma in People Living with HIVInfectious Disease Reports 2022; 14(1): 43 doi: 10.3390/idr14010006
17
Tao Ouyang, Xuefeng Kan, Chuansheng Zheng. Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined TherapiesFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.898964
18
Mina S. Makary, Umang Khandpur, Jordan M. Cloyd, Khalid Mumtaz, Joshua D. Dowell. Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management StrategiesCancers 2020; 12(7): 1914 doi: 10.3390/cancers12071914
19
Katia Pinheiro de Souza, Antonio Rahal, Erivelto Martinho Volpi, Priscila Mina Falsarella, Jairo Tabacow Hidal, Danielle Macellaro Andreoni, Miguel Jose Francisco-Neto, Marcos Roberto Gomes de Queiroz, Rodrigo Gobbo Garcia. Hydrodissection and programmed stop sedation in 100 % of benign thyroid nodules treated with radiofrequency ablationEuropean Journal of Radiology 2020; 133: 109354 doi: 10.1016/j.ejrad.2020.109354
20
Anum Aslam, Richard Kinh Gian Do, Victoria Chernyak, Mishal Mendiratta-Lala. LI-RADS Imaging Criteria for HCC Diagnosis and Treatment: Emerging EvidenceCurrent Hepatology Reports 2020; 19(4): 437 doi: 10.1007/s11901-020-00546-6
21
Sha Yang, Huapeng Lin, Jianning Song. Efficacy and safety of various primary treatment strategies for very early and early hepatocellular carcinoma: a network meta-analysisCancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02365-1
22
Chaohua Lv, Qingsong Wan, Chengxiang Shen, Hongsheng Wu, Bin Zhou, Weiwei Wang. Long non‑coding RNA ZSCAN16‑AS1 promotes the malignant properties of hepatocellular carcinoma by decoying microRNA‑451a and consequently increasing ATF2 expressionMolecular Medicine Reports 2021; 24(5) doi: 10.3892/mmr.2021.12420
23
Kyoko Oura, Asahiro Morishita, Tsutomu Masaki. Molecular and Functional Roles of MicroRNAs in the Progression of Hepatocellular Carcinoma—A ReviewInternational Journal of Molecular Sciences 2020; 21(21): 8362 doi: 10.3390/ijms21218362
24
Congjian Shi, Hongqin Yang, Zhenghong Zhang. Involvement of Nucleotide-Binding Oligomerization Domain-Like Receptor Family Pyrin Domain Containing 3 Inflammasome in the Pathogenesis of Liver DiseasesFrontiers in Cell and Developmental Biology 2020; 8 doi: 10.3389/fcell.2020.00139
25
Mohamed Tantawi, Susan Shamimi-Noori, Colette M. Shaw, John R. Eisenbrey. State of the Art: Contrast Enhanced 4D Ultrasound to Monitor or Assess Locoregional TherapiesDigestive Disease Interventions 2022; 6(01): 003 doi: 10.1055/s-0041-1741520
26
Mina S Makary, Stuart Ramsell, Eric Miller, Eliza W Beal, Joshua D Dowell. Hepatocellular carcinoma locoregional therapies: Outcomes and future horizonsWorld Journal of Gastroenterology 2021; 27(43): 7462-7479 doi: 10.3748/wjg.v27.i43.7462
27
Paula M. Novelli, Philip D. Orons. The role of interventional radiology in the pre-liver transplant patientAbdominal Radiology 2021; 46(1): 124 doi: 10.1007/s00261-020-02704-2
28
Nazli Pinar Karahan Şen, Özkan Alataş, Aytaç Gülcü, Özhan Özdoğan, Erkan Derebek, Gamze Çapa Kaya. The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancerNuclear Medicine Communications 2022; 43(7): 807 doi: 10.1097/MNM.0000000000001572
29
Karolina Galmén, Jan G. Jakobsson, Jacob Freedman, Piotr Harbut. Post‐operative hypertension during early recovery following liver tumour ablation: A retrospective studyActa Anaesthesiologica Scandinavica 2021; 65(9): 1248 doi: 10.1111/aas.13930
30
Yang Hai, Esika Savsani, Weelic Chong, John Eisenbrey, Andrej Lyshchik. Meta-analysis and systematic review of contrast-enhanced ultrasound in evaluating the treatment response after locoregional therapy of hepatocellular carcinomaAbdominal Radiology 2021; 46(11): 5162 doi: 10.1007/s00261-021-03248-9
31
Corina Radu, Petra Fisher, Delia Mitrea, Iosif Birlescu, Tiberiu Marita, Flaviu Vancea, Vlad Florian, Cristian Tefas, Radu Badea, Horia Ștefănescu, Sergiu Nedevschi, Doina Pisla, Nadim Al Hajjar. Integration of Real-Time Image Fusion in the Robotic-Assisted Treatment of Hepatocellular CarcinomaBiology 2020; 9(11): 397 doi: 10.3390/biology9110397
32
Anil C. Anand, Subrat K. Acharya. New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant ChemotherapyJournal of Clinical and Experimental Hepatology 2021; 11(3): 284 doi: 10.1016/j.jceh.2021.04.003
33
Yu-Jen Wu, Wen-Chi Wei, Guo-Fong Dai, Jui-Hsin Su, Yu-Hwei Tseng, Tsung-Chang Tsai. Exploring the Mechanism of Flaccidoxide-13-Acetate in Suppressing Cell Metastasis of Hepatocellular CarcinomaMarine Drugs 2020; 18(6): 314 doi: 10.3390/md18060314
34
Doina Pisla, Vaida Calin, Iosif Birlescu, Nadim Al Hajjar, Bogdan Gherman, Corina Radu, Nicolae Plitea. Risk Management for the Reliability of Robotic Assisted Treatment of Non-resectable Liver TumorsApplied Sciences 2019; 10(1): 52 doi: 10.3390/app10010052
35
Shan Jin, Shisheng Tan, Wen Peng, Ying Jiang, Chunshan Luo. Radiofrequency ablation versus laparoscopic hepatectomy for treatment of hepatocellular carcinoma: a systematic review and meta-analysisWorld Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01966-w
36
Joseph H. Yacoub, Christine C. Hsu, Thomas M. Fishbein, David Mauro, Andrew Moon, Aiwu R. He, Mustafa R. Bashir, Lauren M. B. Burke. Therapies for hepatocellular carcinoma: overview, clinical indications, and comparative outcome evaluation—part one: curative intentionAbdominal Radiology 2021; 46(8): 3528 doi: 10.1007/s00261-021-03069-w
37
Amir A. Borhani, Roberta Catania, Yuri S. Velichko, Stefanie Hectors, Bachir Taouli, Sara Lewis. Radiomics of hepatocellular carcinoma: promising roles in patient selection, prediction, and assessment of treatment responseAbdominal Radiology 2021; 46(8): 3674 doi: 10.1007/s00261-021-03085-w
38
Lei Cao, Yu-Qin Zhu, Zhi-Xian Wu, Gao-Xiong Wang, Hong-Wei Cheng. Engineering nanotheranostic strategies for liver cancerWorld Journal of Gastrointestinal Oncology 2021; 13(10): 1213-1228 doi: 10.4251/wjgo.v13.i10.1213
39
Hidenori Mitani, Akira Naito, Keigo Chosa, Hisayuki Kodama, Masumi Sumida, Takashi Moriya, Kazuo Awai. Safety margin for CT- and US-guided radiofrequency ablation after TACE of HCC in the hepatic domeMinimally Invasive Therapy & Allied Technologies 2022; 31(6): 894 doi: 10.1080/13645706.2021.1995436
40
Anum Aslam, Richard Kinh Gian Do, Avinash Kambadakone, Bradley Spieler, Frank H Miller, Ahmed M Gabr, Resmi A Charalel, Charles Y Kim, David C Madoff, Mishal Mendiratta-Lala. Hepatocellular carcinoma Liver Imaging Reporting and Data Systems treatment response assessment: Lessons learned and future directionsWorld Journal of Hepatology 2020; 12(10): 738-753 doi: 10.4254/wjh.v12.i10.738
41
Qiao Zhang, Feng Xia, Hengyi Gao, Zhenheng Wu, Wenjing Cao, Qingfeng Xiang, Zhifeng Guan, Yang Su, Weiqiao Zhang, Weiqiang Chen, Ali Mo, Shuqun Li. Circulating Tumor Cells as an Indicator of Treatment Options for Hepatocellular Carcinoma Less Than or Equal to 3 cm in Size: A Multi-Center, Retrospective StudyFrontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.895426
42
Roberto Iezzi, Alessandro Posa, Alessandro Tanzilli, Francesca Carchesio, Maurizio Pompili, Riccardo Manfredi. Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCCCardioVascular and Interventional Radiology 2020; 43(11): 1702 doi: 10.1007/s00270-020-02583-6
43
Branislav Radjenović, Martin Sabo, Lukaš Šoltes, Marta Prnova, Pavel Čičak, Marija Radmilović-Radjenović. On Efficacy of Microwave Ablation in the Thermal Treatment of an Early-Stage Hepatocellular CarcinomaCancers 2021; 13(22): 5784 doi: 10.3390/cancers13225784
44
Yi Luo, Lei Song, Xinyu Wang, Yujie Huang, Yongqiang Liu, Qi Wang, Ming Hong, Zhongyu Yuan. Uncovering the Mechanisms of Cryptotanshinone as a Therapeutic Agent Against Hepatocellular CarcinomaFrontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.01264
45
Abdalla Aly, Melissa Lingohr-Smith, Jay Lin, Brian Seal. Locoregional therapy patterns and healthcare economic burden of patients with hepatocellular carcinoma in the USAHepatic Oncology 2021; 8(3) doi: 10.2217/hep-2021-0001
46
Kuo-Liang Wei, Guan-Lun Gao, Yu-Ting Chou, Chih-Yi Lin, Shan-Chun Chen, Yi-Ling Chen, Hui Qin Choi, Chi-Chia Cheng, Jyan-Gwo Joseph Su. Sorafenib is an antagonist of the aryl hydrocarbon receptorToxicology 2022; 470: 153118 doi: 10.1016/j.tox.2022.153118